Carbapenem-Resistant Enterobacteriaceae Infections in Patients on Renal Replacement Therapy | Zendy

Brandon Eilertson | Zendy; Eric Cober | Zendy; Sandra S. Richter | Zendy; Federico Pérez | Zendy; Robert A. Salata | Zendy; Robert C. Kalayjian | Zendy; Richard Watkins | Zendy; Yohei Doi | Zendy; Keith S. Kaye | Zendy; Scott Evans | Zendy; Vance G. Fowler | Zendy; Robert A. Bonomo | Zendy; Jack DeHovitz | Zendy; Barry N. Kreiswirth | Zendy; David van Duin | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Carbapenem-Resistant Enterobacteriaceae Infections in Patients on Renal Replacement Therapy

Author(s) -

Brandon Eilertson,

Eric Cober,

Sandra S. Richter,

Federico Pérez,

Robert A. Salata,

Robert C. Kalayjian,

Richard Watkins,

Yohei Doi,

Keith S. Kaye,

Scott Evans,

Vance G. Fowler,

Robert A. Bonomo,

Jack DeHovitz,

Barry N. Kreiswirth,

David van Duin

Publication year - 2017

Publication title -

open forum infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.546

H-Index - 35

ISSN - 2328-8957

DOI - 10.1093/ofid/ofx216

Subject(s) - medicine , enterobacteriaceae , carbapenem resistant enterobacteriaceae , pathogenic organism , carbapenem , renal replacement therapy , microbiology and biotechnology , intensive care medicine , antibiotics , escherichia coli , biology , biochemistry , gene

Chronic RRT in CRE-infected patients is associated with increased in-hospital mortality and worse disposition outcomes at 28 days.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research